189 related articles for article (PubMed ID: 8698447)
1. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
[TBL] [Abstract][Full Text] [Related]
2. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
3. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
[TBL] [Abstract][Full Text] [Related]
4. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
6. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice. The Syst-Eur Investigators.
Celis H; Yodfat Y; Thijs L; Clement D; Cozic J; De Cort P; Forette F; Grégoire M; Heyrman J; Stibbe G; Van den Haute M; Staessen J; Fagard R
Fam Pract; 1996 Apr; 13(2):138-43. PubMed ID: 8732324
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
[TBL] [Abstract][Full Text] [Related]
9. Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trial.
Antikainen R; Tuomilehto J; Thijs L; Vanhanen H; Sarti C; Birkenhäger W; Arabidze G; Fagard R; Grigorow M; Jankulova K; Jääskivi M; Kohonen-Jalonen P; Laks T; Lazebnic L; Mantova S; Nachev C; Kermova P; Vänskä O; Yodfat Y; Bulpitt CJ; Staessen JA
J Hum Hypertens; 1997 May; 11(5):263-9. PubMed ID: 9205931
[TBL] [Abstract][Full Text] [Related]
10. Determining the trough-to-peak ratio in parallel-group trials. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
Staessen JA; Thijs L; Bijttebier G; Clement D; O'Brien ET; Palatini P; Rodicio JL; Rosenfeld J; Fagard R
Hypertension; 1997 Feb; 29(2):659-67. PubMed ID: 9040453
[TBL] [Abstract][Full Text] [Related]
11. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
[TBL] [Abstract][Full Text] [Related]
13. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
Silagy CA; McNeil JJ; McGrath BP
Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
[TBL] [Abstract][Full Text] [Related]
14. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
15. Syst-Eur--a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
Staessen J; Amery A; Birkenhäger W; Bulpitt CJ; Cox J; de Leeuw P; De Cort P; Fagard R; Fletcher A; Forette F
J Cardiovasc Pharmacol; 1992 Jan; 19(1):120-5. PubMed ID: 1375678
[TBL] [Abstract][Full Text] [Related]
16. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
[TBL] [Abstract][Full Text] [Related]
17. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
Zanchetti A; Omboni S
Am J Hypertens; 2001 Feb; 14(2):129-34. PubMed ID: 11243303
[TBL] [Abstract][Full Text] [Related]
18. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
Wang JG; Staessen JA; Gong L; Liu L
Arch Intern Med; 2000 Jan; 160(2):211-20. PubMed ID: 10647760
[TBL] [Abstract][Full Text] [Related]
19. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial.
Staessen J; Bert P; Bulpitt C; De Cort P; Fagard R; Fletcher A; Kivinen P; Lehtomaki E; Leonetti G; O'Brien E
J Hum Hypertens; 1993 Jun; 7(3):265-71. PubMed ID: 8345494
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
